These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31209398)

  • 41. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Heart rate and outcome in patients with acute and chronic heart failure].
    Oliva F; Ammirati E; Campana C; Carubelli V; Cirò A; Di Tano G; Mortara A; Senni M; Morandi F; Metra M
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 1):3S-16. PubMed ID: 27030005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
    Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies.
    Ma GG; Fang Q; Wang FX
    Cardiol J; 2019; 26(6):744-752. PubMed ID: 30009373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation.
    Moor J; Kuhne M; Moschovitis G; Kobza R; Netzer S; Auricchio A; Beer JH; Bonati L; Reichlin T; Conen D; Osswald S; Rodondi N; Clair C; Baumgartner C; Aubert CE
    Open Heart; 2024 Aug; 11(2):. PubMed ID: 39134361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
    Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
    J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization.
    Laskey WK; Alomari I; Cox M; Schulte PJ; Zhao X; Hernandez AF; Heidenreich PA; Eapen ZJ; Yancy C; Bhatt DL; Fonarow GC;
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
    Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
    Cleland JGF; Bunting KV; Flather MD; Altman DG; Holmes J; Coats AJS; Manzano L; McMurray JJV; Ruschitzka F; van Veldhuisen DJ; von Lueder TG; Böhm M; Andersson B; Kjekshus J; Packer M; Rigby AS; Rosano G; Wedel H; Hjalmarson Å; Wikstrand J; Kotecha D;
    Eur Heart J; 2018 Jan; 39(1):26-35. PubMed ID: 29040525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
    Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.
    Lam SHM; Romiti GF; Olshansky B; Chao TF; Huisman MV; Lip GYH
    Intern Emerg Med; 2024 Aug; 19(5):1369-1378. PubMed ID: 38780748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program.
    Castagno D; Skali H; Takeuchi M; Swedberg K; Yusuf S; Granger CB; Michelson EL; Pfeffer MA; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2012 May; 59(20):1785-95. PubMed ID: 22575317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exercise Ventricular Rates, Cardiopulmonary Exercise Performance, and Mortality in Patients With Heart Failure With Atrial Fibrillation.
    Elshazly MB; Wilkoff BL; Tarakji K; Wu Y; Donnellan E; Abi Khalil C; Asaad N; Jaber W; Wazni O; Cho L
    Circ Heart Fail; 2021 Feb; 14(2):e007451. PubMed ID: 33478244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?
    Franke J; Wolter JS; Meme L; Keppler J; Tschierschke R; Katus HA; Zugck C
    Clin Res Cardiol; 2013 Jan; 102(1):23-31. PubMed ID: 22760479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostically Optimal Heart Rate at Discharge in Hospitalized Patients With Heart Failure and Atrial Fibrillation.
    Kishihara M; Kawakami R; Fukushima N; Abe T; Takada T; Shirotani S; Yoshida A; Hata T; Watanabe S; Kawamoto T; Hasegawa S; Yamaguchi J; Jujo K
    JACC Adv; 2024 Aug; 3(8):101120. PubMed ID: 39156115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.